The latest on Feldan products and innovations. Check our blog regularly to stay informed.

Feldan will attend RESI in Boston

For a second year in a row, Feldan is selected to participate in the RESI X Innovation Challenge in Boston! About the RESI Conference The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and […]

Feldan’s poster presented at ASGCT 2016 last month!

Our research director David Guay participated at the American Society of Gene & Cell Therapy in Washington DC last month. Gene therapy field is booming, ASGCT is a great opportunity to appreciate the latest development. Dr Guay presented the latest research on the Shuttle technology for the delivery of Cas9 recombinant protein and recombinant transcription factors […]

Feldan is attending BIO 2016

Our CEO, Francois-Thomas Michaud and Product Director, Vincent Menard will be attending BIO 2016 next week in San Francisco.  If you are attending, do not hesitate to let us know! About Bio International Convention The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, […]

Feldan is attending the Annual meeting of ASGCT in Washington DC, USA.

      Come meet our Research Director, David Guay to learn more about our Shuttle technology during the 19th Annual Meeting of the American Society of Gene and Cell Therapy ASGCT In Washington DC, USA on May 4th-7th 2016. Poster Presentation: Friday May 6th, 2016 – 6:00pm – 8:00pm About American Society of Gene […]

Feldan’s CEO in the newspaper Les Affaires

  Feldan’s CEO, François-Thomas Michaud, is part of the article “10 engineers who build the future” (traduction de 10 Ingénieurs qui bâtissent l’avenir) in the newspaper Les Affaires (Article in French). The article talks about Dr. Michaud and his career as an “engineer who became a business entrepreneur” of Feldan. Article: Des protéines qui aident […]

Feldan promotes Genome Editing in Canada

  In a burst to promote Genome editing in Canada, Feldan would like to offer a 15% discount on the purchase of our Recombinant Cas9 to all Canadian researchers working in the field of genome editing. *Promotion valid until June 1st 2016, use promo code CAN2016 when ordering via email at Why choose Feldan […]

Learn about Feldan’s CEO, Francois-Thomas Michaud

              Here is an article in the Newspaper Le Soleil about Feldan’s CEO, Francois-Thomas Michaud. Learn more about Feldan and its CEO. Article in Le Soleil (in french)    

Quick survey for Cas9 user!

There are lots of unanswered questions regarding the use of Cas9. We would like to elucidate some of them! But we need your help! Take a few minutes to answer these quick questions! Results will be published later on ! Thank you for your time! Click Here for Survey!

Participation de Feldan Therapeutics à BioConnexion2016

    Notre CEO Francois-Thomas Michaud participera à l’événement BioConnexion 2016 qui aura lieu le 15 Mars 2016 au pavillon Alphonse-Desjardin de l’Université Laval. Cet évènement de réseautage unique organisé par PROTÉO s’adresse plus particulièrement aux étudiants de biochimie, microbiologie, biologie, chimie et de génie chimique. À propos de PROTÉO PROTEO, le regroupement québécois de […]

Great review on the delivery of CRISPR/Cas9 system into cells

Article: Cell biology: delivering tough cargo into cells This article from Nature Methods was published in one of our LinkedIn Group last week and we thought we could share it as it is a great overview of different techniques used to deliver cargos inside cells and more precisely, the CRISPR/Cas9 system. At Feldan Therapeutics, we […]